<h1>Rubber company launches 35+ rubber sheets with FDA and '2025 standards' testing claims, risking false advertising and compliance liabilities</h1> A rubber-products company announced a launch of 35+ natural and synthetic rubber sheets, new tiered product categories, labeled technical specs, asserted FDA approval for certain grades, and testing 'as per 2025 standards,' plus expedited ordering and global distribution. Legally relevant issues include the risk of regulatory noncompliance or liability if certifications or testing claims (FDA, standards) are inaccurate or unsupported; potential consumer protection and false-advertising exposure from technical or performance assertions; contract, warranty and export-compliance obligations when supplying OEMs and international customers; and safety-certification requirements for the forthcoming electrical mats.